EMERGING TRENDS IN THE MANAGEMENT OF GESTATIONAL DIABETES MELLITUS REVIEW

Abstract

https://doi.org/10.71000/9k5p4q40

Background: Gestational diabetes mellitus (GDM) represents one of the most frequent metabolic complications during pregnancy, bringing substantial short- and long-term hazards for both the mother and the infant. Increasing maternal age, rising obesity rates, and sedentary habits have driven its expanding worldwide prevalence. Prompt and effective GDM care is essential for enhancing perinatal results and averting future metabolic illnesses.

Objective: This narrative review intends to investigate current developments in GDM management, covering progress in screening protocols, nutritional and pharmaceutical therapies, and the incorporation of digital resources into clinical workflows.

Main Discussion Points: Contemporary literature highlights a transition toward personalized care strategies, uniting tailored exercise and dietary therapy as foundational treatment. Medical choices have grown to encompass insulin analogs and oral hypoglycemic drugs like metformin, though long-term safety records continue to be scarce. Innovations in digital health—specifically continuous glucose monitoring systems—provide improved patient participation and glucose tracking. Nevertheless, discrepancies in diagnostic thresholds, outcome metrics, and follow-up routines restrict the comparability of trials. Furthermore, the generalizability of conclusions is limited by participant homogeneity and an underrepresentation of low-resource environments.

Conclusion: Emerging approaches are transforming GDM treatment toward more technology-integrated, personalized frameworks. While evidence backs the efficacy of multiple novel interventions, existing literature displays notable methodological flaws. Upcoming investigations should focus on large-scale, multiethnic, and longitudinal studies to shape standardized clinical guidelines and ensure equitable care delivery.